Mohammad Farsangi-Hojjat

Stockholm, AB, Sweden

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 118 publications

Retraction notice to "Silencing STAT3 enhances sensitivity of cancer cells to doxorubicin and inhibits tumor progression" [Life Sci. 275 (2021) 119369].

Retraction notice to "Silencing STAT3 enhances sensitivity of cancer cells to doxorubicin and inhibits tumor progression" [Life Sci. 275 (2021) 119369].

Journal: Life sciences
Published: October 02, 2025

Retraction notice to "Blockade of CD73 using siRNA loaded chitosan lactate nanoparticles functionalized with TAT-hyaluronate enhances doxorubicin mediated cytotoxicity in cancer cells both in vitro and in vivo" [Int. J. Biol. Macromol. 186 (2021) 849-863].

Retraction notice to "Blockade of CD73 using siRNA loaded chitosan lactate nanoparticles functionalized with TAT-hyaluronate enhances doxorubicin mediated cytotoxicity in cancer cells both in vitro and in vivo" [Int. J. Biol. Macromol. 186 (2021) 849-863].

Journal: International journal of biological macromolecules
Published: August 07, 2025

Retraction notice to "Silencing of IL-6 and STAT3 by siRNA loaded hyaluronate-N,N,N-trimethyl chitosan nanoparticles potently reduces cancer cell progression" [Int. J. Biol. Macromol. 149 (2020) 487-500].

Retraction notice to "Silencing of IL-6 and STAT3 by siRNA loaded hyaluronate-N,N,N-trimethyl chitosan nanoparticles potently reduces cancer cell progression" [Int. J. Biol. Macromol. 149 (2020) 487-500].

Journal: International journal of biological macromolecules
Published: August 06, 2025

Conditioned plasma promotes full-thickness skin defect healing in a rat model.

Conditioned plasma promotes full-thickness skin defect healing in a rat model.

Journal: Regenerative therapy
Published: July 15, 2025

Platelet Activation Enhances Bioactive Molecules Concentration in Platelet Rich Plasma.

Platelet Activation Enhances Bioactive Molecules Concentration in Platelet Rich Plasma.

Journal: Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion
Published: June 22, 2025

Long noncoding RNAs in acute myeloid leukemia: biomarkers, prognostic indicators, and treatment potential.

Long noncoding RNAs in acute myeloid leukemia: biomarkers, prognostic indicators, and treatment potential.

Journal: Cancer cell international
Published: January 20, 2025

The emerging role of TIM-3 in colorectal cancer: a promising target for immunotherapy.

The emerging role of TIM-3 in colorectal cancer: a promising target for immunotherapy.

Journal: Expert opinion on therapeutic targets
Published: December 13, 2024

A Small Molecule Antagonist of CX3CR1 (KAND567) Inhibited the Tumor Growth-Promoting Effect of Monocytes in Chronic Lymphocytic Leukemia (CLL).

A Small Molecule Antagonist of CX3CR1 (KAND567) Inhibited the Tumor Growth-Promoting Effect of Monocytes in Chronic Lymphocytic Leukemia (CLL).

Journal: Cancers
Published: September 20, 2024

Intradermal lymphocyte therapy: A promising treatment for recurrent pregnancy loss in patients without anti-TPO antibodies.

Intradermal lymphocyte therapy: A promising treatment for recurrent pregnancy loss in patients without anti-TPO antibodies.

Journal: Human immunology
Published: July 31, 2024

The prognostic and therapeutic potential of vimentin in colorectal cancer.

The prognostic and therapeutic potential of vimentin in colorectal cancer.

Journal: Molecular biology reports
Published: June 15, 2024

Retraction notice to "Simultaneous silencing of the A2aR and PD-1 immune checkpoints by siRNA-loaded nanoparticles enhances the immunotherapeutic potential of dendritic cell vaccine in tumor experimental models" [Life Sci. 288 (2022) 120166].

Retraction notice to "Simultaneous silencing of the A2aR and PD-1 immune checkpoints by siRNA-loaded nanoparticles enhances the immunotherapeutic potential of dendritic cell vaccine in tumor experimental models" [Life Sci. 288 (2022) 120166].

Journal: Life sciences
Published: June 09, 2024

Retraction notice to "Codelivery of BV6 and anti-IL6 siRNA by hyaluronate-conjugated PEG-chitosan-lactate nanoparticles inhibits tumor progression" [Life Sci. 260 (2020) 118423].

Retraction notice to "Codelivery of BV6 and anti-IL6 siRNA by hyaluronate-conjugated PEG-chitosan-lactate nanoparticles inhibits tumor progression" [Life Sci. 260 (2020) 118423].

Journal: Life sciences
Published: June 07, 2024
Showing 1-12 of 118

Last Updated: 09/26/2026